The speaker in "the tropics in New York" weep at the end of the poem because He is overwhelmed with nostalgia for the home of his past.
<h3>Why does the speaker in the tropics in New York weep?</h3>
In "The Tropics in New York," is known to be a poem that tells about the memories of the speaker.
The reason why I think the speaker weeps is that The poet is trying to remembering her homeland and as such, he weeps because she misses it.
Learn more about the poem from
brainly.com/question/20154783
Answer:
but I have only one that is this
Answer:
a little late but ok xD
LAST CHRISTMAS I GAVE U MY HEARTT!!!
Answer:
Cancer is the name given to a collection of related diseases. Cancer is more than one type of disease. In cancer, as a result of genetic mutations, this regulatory process malfunctions, resulting in uncontrolled cell proliferation. CAD, Stroke, Respiratory illness, COPD are all diseases related to cancer. Inherited genetic mutations play a major role in about 5 to 10 percent of all cancers. There are many environmental pathogenic factors that can cause cancer. For example , Tar and Coal-Tar Pitch , Emissions , Secondhand Tobacco Smoke (Environmental Tobacco Smoke) , Arsenic , Soot , Asbestos , Wood Dust. When cancer cells break away from a tumor, they can travel to other parts of the body through the bloodstream or the lymph system. Cancer is hard to treat in later stages because it probably has already spread through out the body. The grade of a cancer depends on what the cells look like under a microscope. In general, a lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one. Some examples of cancer treatments of cancer are, Surgery, Chemotherapy, Radiotherapy, Cancer drugs, Hormone therapy, Stem cell and bone marrow transplants, Targeted cancer drugs. A new treatment involving a photosensitising agent that makes cells more sensitive to light and, by doing so, causes cancer cells to
be destroyed when a laser light is directed on a cancerous area. One challenge is, druggable genomic alterations are diverse and represent only small subsets of patients in certain tumor types, which limits testing their clinical impact in biomarker-driven clinical trials. Next-generation sequencing technologies are increasingly being implemented for molecular prescreening in clinical research, but issues regarding clinical interpretation of large genomic data make their wide clinical use difficult.
Explanation:
